MedTrace Logo

Probiotics, Antibiotics and the Post-Antibiotic Microbiota

NCT07425704 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-03-18

No results posted yet for this study

Summary

Antibiotic therapy can cause gastrointestinal dysbiosis and this study will assess the impact of probiotic supplementation on microbiological composition and functionality pre- and post- antibiotic therapy

Conditions

  • Probiotic
  • Microbiome

Interventions

DIETARY_SUPPLEMENT

Lab4S

Probiotic containing lactic acid bacteria and Saccharomyces boulardii at a dose of 35 billion per day

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Cultech Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-13
Primary Completion
2026-10-01
Completion
2026-12-01

Countries

  • Bulgaria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07425704 on ClinicalTrials.gov